Vaccination in inflammatory bowel disease

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 168-

  Cullen, Garret ^a   Baden, Rachel P ^a   Cheifetz, Adam S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERITIS; IMMUNOCOMPROMISED PATIENT; LETTER; PRIORITY JOURNAL; VACCINATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

CHICKENPOX VACCINE; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RISK ASSESSMENT; VACCINATION; VACCINES, ATTENUATED;

EID: 78650972869     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.382     Document Type: Letter

References (7)

1. Wasan SK, Baker SE, Skolnik PR et al. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010; 105: 1231-8.
2. Block SL, Yogev R, Hayden FG et al. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Vaccine 2008; 26: 4940-6.
3. Izurieta HS, Haber P, Wise RP et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005; 294: 2720-5.
4. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58: 1-25.
5. Kroger AT, Atkinson WL, Marcuse EK et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55: 1-48.
6. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA 2003; 289: 3278-82.
7. Kamboj M, Sepkowitz KA. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infect Control Hosp Epidemiol 2007; 28: 702-7.